Jamie Murphy
Comptroller/Controller/Auditor at SIGILON THERAPEUTICS, INC.
Profile
Jamie Murphy is currently the Vice President-Finance & Controller at Sigilon Therapeutics, Inc. Prior to this, he worked as a Controller at Zafgen, Inc. and as a Financial Consultant at Larimar Therapeutics, Inc. Mr. Murphy completed his undergraduate degree at Wake Forest University and his graduate studies, including an MBA, at Northeastern University.
Jamie Murphy active positions
| Companies | Position | Start |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Former positions of Jamie Murphy
| Companies | Position | End |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| LARIMAR THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Training of Jamie Murphy
| Wake Forest University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Jamie Murphy
